InvestorsHub Logo
Followers 25
Posts 1777
Boards Moderated 0
Alias Born 12/23/2011

Re: None

Friday, 02/26/2021 12:43:16 PM

Friday, February 26, 2021 12:43:16 PM

Post# of 640
This article explains what's going on with Citius ($CTXR)
Exciting things!

From Article:

"Most notable is that insiders have invested $26.5M of their own money into Citius. As of Sept 2019 Mazur & Holubiak held over 12.2M shares and have not sold any. According to Yahoo! Finance insiders hold 39% of all shares. It is rare in clinical biotechs for management to have such a high percentage of ownership and it speaks to their confidence in eventual drug approval.

Price Targets
Dawson James recently gave Citius a price target of $8 and noted that CTXR is funded all the way through commercialization. This is HUGE!"

https://seekingalpha.com/instablog/50299941-north-shore-research/5557969-ctxr-blockbuster-pharma-still-under-radar
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTXR News